EGR1 Regulation of Vasculogenic Mimicry in the MDA-MB-231 Triple-Negative Breast Cancer Cell Line through the Upregulation of KLF4 Expression

被引:3
|
作者
Jung, Euitaek [1 ]
Lee, Young Han [1 ,2 ]
Ou, Sukjin [1 ]
Kim, Tae Yoon [1 ]
Shin, Soon Young [1 ,2 ]
机构
[1] Konkuk Univ, Dept Biol Sci, Sanghuh Coll Life Sci s, Seoul 05029, South Korea
[2] Konkuk Univ, Canc & Metab Inst, Seoul 05029, South Korea
关键词
Early Growth Response 1; Kruppel-like factor 4; MDA-MB-231; cells; mitogen-activated protein kinase pathway; vasculogenic mimicry; EMT;
D O I
10.3390/ijms241814375
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vasculogenic mimicry (VM) is an intriguing phenomenon observed in tumor masses, in which cancer cells organize themselves into capillary-like channels that closely resemble the structure and function of blood vessels. Although VM is believed to contribute to alternative tumor vascularization, the detailed regulatory mechanisms controlling these cellular processes remain poorly understood. Our study aimed to investigate the role of Early Growth Response 1 (EGR1) in regulating VM in aggressive cancer cells, specifically MDA-MB-231 triple-negative breast cancer cells. Our study revealed that EGR1 promotes the formation of capillary-like tubes by MDA-MB-231 cells in a 3-dimensional Matrigel matrix. EGR1 was observed to upregulate Kruppel-like factor 4 (KLF4) expression, which regulates the formation of the capillary-like tube structure. Additionally, our findings highlight the involvement of the ERK1/2 and p38 mitogen-activated protein kinase pathways in mediating the expression of EGR1 and KLF4, underscoring their crucial role in VM in MDA-MB-231 cells. Understanding these regulatory mechanisms will provide valuable insights into potential therapeutic targets for preventing VM during the treatment of triple-negative breast cancer.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Suppression of migration and invasion by taraxerol in the triple-negative breast cancer cell line MDA-MB-231 via the ERK/Slug axis
    Xia, Yu-ting
    Zhang, Yu-qin
    Chen, Lu
    Min, Liangliang
    Huang, Da
    Zhang, Yulu
    Li, Cong
    Li, Zhi-hua
    PLOS ONE, 2023, 18 (09):
  • [22] Regulation of the Plasminogen Activator System in the MDA-MB-231 Breast Cancer Cell Line
    Gramling, Mark Wilson
    Hawkins, Leah K.
    Sandhu, Emir S.
    Church, Frank C.
    FASEB JOURNAL, 2008, 22
  • [23] Liposomal-Naringenin Radiosensitizes Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro
    Pearce, Keenau
    Cairncross, Samantha I.
    Benjeddou, Mongi
    IET NANOBIOTECHNOLOGY, 2024, 2024
  • [24] The Triple-negative Breast Cancer Cell Line MDA-MB 231 Is Specifically Inhibited by the Ionophore Salinomycin
    Hero, Thomas
    Buehler, Helmut
    Kouam, Pascaline Nguemgo
    Priesch-Grzeszowiak, Bettina
    Lateit, Tatiana
    Adamietz, Irenaus Anton
    ANTICANCER RESEARCH, 2019, 39 (06) : 2821 - 2827
  • [25] Pereskia bleo augments NK cell cytotoxicity against triple-negative breast cancer cells (MDA-MB-231)
    Khalaf, Taif Kareem
    Ismail, Norzila
    Nazri, Nor Amalia
    Ahmed, Naveed
    Yajid, Aidy Irman
    Mohamud, Rohimah
    Kadir, Ramlah
    PEERJ, 2024, 12
  • [26] Pyoluteorin induces cell cycle arrest and apoptosis in human triple-negative breast cancer cells MDA-MB-231
    Ding, Ting
    Yang, Luo-Jie
    Zhang, Wei-Dong
    Shen, Yun-Heng
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2020, 72 (07) : 969 - 978
  • [27] Cell cycle arrest-mediated cell death by morin in MDA-MB-231 triple-negative breast cancer cells
    Sushma Maharjan
    Yun-Suk Kwon
    Min-Gu Lee
    Kyu-Shik Lee
    Kyung-Soo Nam
    Pharmacological Reports, 2021, 73 : 1315 - 1327
  • [28] Cell cycle arrest-mediated cell death by morin in MDA-MB-231 triple-negative breast cancer cells
    Maharjan, Sushma
    Kwon, Yun-Suk
    Lee, Min-Gu
    Lee, Kyu-Shik
    Nam, Kyung-Soo
    PHARMACOLOGICAL REPORTS, 2021, 73 (05) : 1315 - 1327
  • [29] Thymoquinone Anticancer Effects Through the Upregulation of NRF2 and the Downregulation of PD-L1 in MDA-MB-231 Triple-Negative Breast Cancer Cells
    Adinew, Getinet
    Messeha, Samia S.
    Badisa, Ramesh
    Taka, Equar
    Soliman, Karam F. A.
    FASEB JOURNAL, 2022, 36
  • [30] MCL1 Inhibition Overcomes the Aggressiveness Features of Triple-Negative Breast Cancer MDA-MB-231 Cells
    Pratelli, Giovanni
    Carlisi, Daniela
    Di Liberto, Diana
    Notaro, Antonietta
    Giuliano, Michela
    D'Anneo, Antonella
    Lauricella, Marianna
    Emanuele, Sonia
    Calvaruso, Giuseppe
    De Blasio, Anna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (13)